Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
May 10, 2024 $6.32 $6.43 $5.88 $6.01 1 603 937
May 09, 2024 $6.13 $6.73 $6.13 $6.36 1 904 158
May 08, 2024 $6.13 $6.29 $5.99 $6.08 1 462 277
May 07, 2024 $6.46 $6.46 $6.05 $6.16 871 115
May 06, 2024 $6.50 $6.73 $6.28 $6.41 808 550
May 03, 2024 $6.43 $7.00 $6.28 $6.41 1 386 404
May 02, 2024 $6.13 $6.25 $6.00 $6.15 928 599
May 01, 2024 $6.04 $6.56 $5.84 $6.00 1 764 037
Apr 30, 2024 $6.09 $6.31 $5.96 $6.01 991 463
Apr 29, 2024 $6.22 $6.54 $6.11 $6.26 917 745
Apr 26, 2024 $6.26 $6.41 $6.02 $6.16 767 147
Apr 25, 2024 $6.28 $6.35 $6.05 $6.22 1 216 670
Apr 24, 2024 $6.87 $6.92 $6.53 $6.58 985 338
Apr 23, 2024 $6.90 $7.41 $6.83 $6.88 963 342
Apr 22, 2024 $6.75 $7.03 $6.46 $6.91 887 966
Apr 19, 2024 $6.59 $6.80 $6.42 $6.64 1 064 681
Apr 18, 2024 $6.70 $6.85 $6.53 $6.66 1 223 643
Apr 17, 2024 $7.23 $7.27 $6.72 $6.74 1 108 931
Apr 16, 2024 $7.15 $7.26 $7.04 $7.14 678 779
Apr 15, 2024 $7.73 $7.73 $7.13 $7.31 1 366 067
Apr 12, 2024 $7.99 $8.02 $7.54 $7.60 1 185 278
Apr 11, 2024 $8.40 $8.40 $7.90 $8.07 1 074 733
Apr 10, 2024 $8.25 $8.32 $7.76 $8.01 1 708 984
Apr 09, 2024 $8.43 $8.77 $8.37 $8.75 868 780
Apr 08, 2024 $8.75 $8.75 $8.24 $8.40 984 149
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT